Tempus studied over 5,500 advanced NSCLC patients and found that using both RNA and DNA sequencing identified significantly more actionable genetic variants than DNA testing alone—boosting detection ...
IlluminaThe comprehensive method provides improved detection and greater insight on the complex disease that impacts millions of people worldwideOriginally published on Illumina News CenterThe ...